<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To report the effect of a single intravitreal bevacizumab injection on serous <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> (SRD) in <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome (SWS)</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Interventional case report </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A 15-year-old boy with history of SWS was referred with a complaint of sudden <z:hpo ids='HP_0000572'>visual loss</z:hpo> 2 days before, having choroidal <z:hpo ids='HP_0001028'>hemangioma</z:hpo> accompanied with SRD </plain></SENT>
<SENT sid="3" pm="."><plain>Visual acuity was 20/160 </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: He was treated with 1.25 mg of bevacizumab injected intravitreally </plain></SENT>
<SENT sid="5" pm="."><plain>One week later, the retina was completely attached and visual acuity was 20/20 </plain></SENT>
<SENT sid="6" pm="."><plain>After 20 months, without repeating the injection, the retina remained attached and vision was stable </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: An early single dose of intravitreal bevacizumab is effective in the treatment of serous <z:hpo ids='HP_0000541'>retinal detachment</z:hpo> in SWS with good long-term results </plain></SENT>
</text></document>